title: Mucosal immunization with virus-like particles of simian immunodeficiency virus conjugated with cholera toxin subunit B.
abstract: To enhance the efficiency of antigen uptake at mucosal surfaces, CTB was conjugated to simian immunodeficiency virus (SIV) virus-like particles (VLPs). We characterized the immune responses to the Env and Gag proteins after intranasal administration. Intranasal immunization with a mixture of VLPs and CTB as an adjuvant elicited higher levels of SIV gp160-specific immunoglobulin G (IgG) in sera and IgA in mucosae, including saliva, vaginal-wash samples, lung, and intestine, as well as a higher level of neutralization activities than immunization with VLPs alone. Conjugation of CTB to VLPs also enhanced the SIV VLP-specific antibodies in sera and in mucosae to similar levels. Interestingly, CTB-conjugated VLPs showed higher levels of cytokine (gamma interferon)-producing splenocytes and cytotoxic-T-lymphocyte activities of immune cells than VLPs plus CTB, as well as an increased level of both IgG1 and IgG2a serum antibodies, which indicates enhancement of both Th1- and Th2-type cellular immune responses. These results demonstrate that CTB can be an effective mucosal adjuvant in the context of VLPs to induce enhanced humoral, as well as cellular, immune responses.
authors.affiliation: Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA.
authors.forename: Sang-Moo
authors.initials: SM
authors.lastname: Kang
authors.forename: Qizhi
authors.initials: Q
authors.lastname: Yao
authors.forename: Lizheng
authors.initials: L
authors.lastname: Guo
authors.forename: Richard W
authors.initials: RW
authors.lastname: Compans
mesh_terms: D000281:Administration, Intranasal; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D002772:Cholera Toxin / Q000008:administration & dosage* / Q000494:pharmacology; D007114:Immunization; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis; D007074:Immunoglobulin G / Q000097:blood / Q000145:classification; D007371:Interferon-gamma / Q000096:biosynthesis; D015847:Interleukin-4 / Q000096:biosynthesis; D018449:SAIDS Vaccines / Q000008:administration & dosage / Q000276:immunology*; D018411:Spodoptera; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D018074:Vaccines, Conjugate / Q000276:immunology; D014771:Virion / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D007071:Immunoglobulin A, Secretory; D007074:Immunoglobulin G; D018449:SAIDS Vaccines; D018074:Vaccines, Conjugate; D015847:Interleukin-4; D007371:Interferon-gamma; D002772:Cholera Toxin